Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated（CORT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CORT · 截至 2026年6月8日
活动摘要
买入笔数
2
P-Purchase only
卖出笔数
73
近12个月
买卖比
0.03
Buy/Sell (by trades)
整体情绪
Corcept Therapeutics Incorporated内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
CORT 季度内部人买卖趋势
CORT 内幕交易卖出 · CORT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · CORT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CORT 高管卖出股份 · CORT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 2, 2026 | Guyer William Chief Development Officer | Option | 20,000 | $433K | Form 4 |
| Jun 2, 2026 | Guyer William Chief Development Officer | Sale | 20,000 | $1.41M⚡ | Form 4 |
| Jun 1, 2026 | Lyon Joseph Douglas See Remarks | Award | 537 | — | Form 4 |
| Jun 2, 2026 | Lyon Joseph Douglas See Remarks | Other | 269 | $19K | Form 4 |
| Jun 1, 2026 | Lyon Joseph Douglas See Remarks | Award | 537 | $38K | Form 4 |
| Jun 1, 2026 | Guyer William Chief Development Officer | Award | 877 | — | Form 4 |
| Jun 1, 2026 | Guyer William Chief Development Officer | Award | 877 | $62K | Form 4 |
| Jun 1, 2026 | Maduck Sean See Remarks | Option | 25,000 | $207K | Form 4 |
| Jun 1, 2026 | Maduck Sean See Remarks | Sale | 21,069 | $1.48M⚡ | Form 4 |
| Jun 1, 2026 | Maduck Sean See Remarks | Award | 615 | — | Form 4 |
| Jun 2, 2026 | Maduck Sean See Remarks | Other | 452 | $32K | Form 4 |
| Jun 1, 2026 | Maduck Sean See Remarks | Award | 615 | $43K | Form 4 |
| Jun 1, 2026 | Maduck Sean See Remarks | Sale | 3,931 | $278K | Form 4 |
| Jun 1, 2026 | Mokari Atabak CFO | Option | 40,000 | $770K | Form 4 |
| Jun 1, 2026 | Mokari Atabak CFO | Award | 634 | — | Form 4 |
| Jun 2, 2026 | Mokari Atabak CFO | Other | 395 | $28K | Form 4 |
| Jun 1, 2026 | Mokari Atabak CFO | Award | 634 | $45K | Form 4 |
| Jun 1, 2026 | Mokari Atabak CFO | Sale | 40,000 | $2.80M⚡ | Form 4 |
| Jun 1, 2026 | Robb Gary Charles Chief Business Officer | Award | 776 | — | Form 4 |
| Jun 2, 2026 | Robb Gary Charles Chief Business Officer | Other | 358 | $25K | Form 4 |
| Jun 1, 2026 | Robb Gary Charles Chief Business Officer | Award | 776 | $55K | Form 4 |
| May 29, 2026 | BELANOFF JOSEPH K CEO · Director | Gift | 300,000 | — | Form 4 |
| Jun 1, 2026 | BELANOFF JOSEPH K CEO · Director | Sale | 12,837 | $895K | Form 4 |
| May 29, 2026 | BELANOFF JOSEPH K CEO · Director | Gift | 150,000 | — | Form 4 |
| May 27, 2026 | Lyon Joseph Douglas See Remarks | Sale | 5,000 | $325K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CORT 内幕交易
CORT 内幕交易
Corcept Therapeutics Incorporated（CORT）内幕交易数据来源于公司内部人（包括Maduck Sean (See Remarks), Guyer William (Chief Development Officer), WILSON JAMES N (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。CORT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Corcept Therapeutics Incorporated机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CORT 内幕交易 · 5个问题Corcept Therapeutics Incorporated（CORT）的内部人包括高管和董事，如Maduck Sean (See Remarks), Guyer William (Chief Development Officer), WILSON JAMES N (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026